TMS for Anxiety: Where the Evidence Is Strong and Where It's Still Thin

You’ve tried the medication, maybe two. You’ve done some therapy, and the worry still hums under everything. So when a clinic ad says magnetic pulses can calm an anxious brain without another pill, it’s hard not to hope.

Anxiety runs through brain circuits, and those circuits communicate with electrical signals. Transcranial magnetic stimulation (TMS) uses a magnetic coil held against your scalp to create small electrical currents in a chosen brain region, with no surgery and no anesthesia. NIMH’s brain stimulation overview explains that the magnetic field is about as strong as an MRI’s and is aimed at one specific site, a level of precision that sets it apart from electroconvulsive therapy, which stimulates the brain more broadly.

The established treatments for anxiety are therapy and medication. NIMH’s GAD guide describes cognitive behavioral therapy (CBT) as the gold-standard psychotherapy and lists SSRIs and SNRIs among effective medications. A Lancet network meta-analysis of 89 trials found several of those medications more effective than placebo. The results are real, and the science is well established.

Those treatments don’t help everyone, and at Siggy we’d rather show you exactly where TMS fits than repeat a sales pitch the evidence doesn’t back.

The better approach is evidence-matched care. That means using TMS where the data are strongest, for anxiety that travels with depression after medication hasn’t worked, and treating the smaller anxiety-only trials as promising but unproven. It targets the same overactive worry the standard treatments do, with expectations set by what the trials actually measured, and the line we’re drawing comes from the evidence rather than from marketing.

What This Page Covers

• What Is TMS and How Is It Supposed to Help Anxiety?
• Is TMS FDA-Cleared for Anxiety?
• What Does the Research Show for Generalized Anxiety Disorder?
• What About PTSD, Panic Disorder, and OCD?
• What Is a Course of TMS Like?
• Who Might Be a Good Candidate for TMS?
• What Should You Try Before TMS?
• How Siggy Fits In
• Start With an Honest Read of Where You Are

What Is TMS and How Is It Supposed to Help Anxiety?

TMS is a noninvasive treatment that uses an electromagnet to deliver repeated low-intensity pulses to the brain. NIMH explains that the magnetic field switches on and off very rapidly, which induces weak electrical currents that stimulate neurons and neural circuits. Pulses delivered in a repeated series are called repetitive TMS (rTMS), and in deep TMS the coil setup is designed to target larger structures deeper in the brain.

During a session, a technician holds the coil against your head near brain areas involved in mood regulation and cognitive control. You stay awake, and most people feel a light tapping on the scalp as the pulses fire. Our guide to what TMS therapy is covers the basics in more detail.

The left dorsolateral prefrontal cortex, near the front of the brain, is the most common TMS target, and researchers have tested whether stimulating it eases anxiety as well as depression. So far, the effect on anxiety looks smaller. A 2023 cross-diagnostic meta-analysis pooled 174 sham-controlled trials with 7,905 patients. Stimulating the left dorsolateral prefrontal cortex had a medium effect on depressive symptoms and a small effect on anxiety.

Is TMS FDA-Cleared for Anxiety?

TMS is FDA-cleared for anxiety only when it comes with major depression, and only for specific devices. In August 2021, the FDA cleared a BrainsWay deep TMS device, under FDA clearance K210201, for depressive episodes and for decreasing anxiety symptoms in adults with major depressive disorder who hadn’t improved enough on antidepressant medication in their current episode. FDA clearance K220127 extended the same indication to another device in 2022, and each clearance covers a particular device and protocol.

According to the 510(k) summary BrainsWay filed, the 2021 clearance rested on 3 randomized controlled trials plus supportive pooled data from 11 studies covering 573 patients. Across the 3 trials, the pooled effect on anxiety symptoms was 0.55, which the summary describes as a medium effect. NIMH lists the conditions rTMS is cleared for as treatment-resistant depression, OCD, migraines, anxiety with depression, and smoking dependence. Generalized anxiety disorder, panic disorder, and social anxiety disorder aren’t on that list, so using TMS for them is off-label.

Here’s how the FDA status and the strength of the evidence line up across conditions:

Condition	FDA Status	Evidence Snapshot
Major depression after medication	Cleared since 2008	Strong
Anxiety symptoms with major depression	Cleared since 2021	Medium effect in 3 trials
OCD	Cleared since 2018	Moderate, more responders than sham
Generalized anxiety disorder alone	Not cleared	Low strength, small trials
PTSD	Not cleared	Low strength, small trials
Panic disorder	Not cleared	Too few studies to judge

The FDA dates come from NIMH’s overview and the 510(k) records above, and each clearance applies to specific devices and protocols. The evidence ratings come from NIMH’s description of the depression data, the 510(k) summary, and the reviews covered in the next two sections.

What Does the Research Show for Generalized Anxiety Disorder?

The early numbers look impressive. A 2022 meta-analysis pooled 6 rTMS studies with 152 patients and reported a large drop in anxiety scores. Its authors described the studies as limited and varied, and they called for rigorous randomized trials as an urgent need.

The most careful review so far is more cautious. A 2026 RTI review looked at 20 sham-controlled trials of TMS for GAD, OCD, and PTSD. It found no evidence that TMS helped more people reach remission than sham for any of the three conditions. For GAD, it concluded TMS may improve symptom severity, but it rated that evidence low strength. It also noted that many trials were small, carried a high risk of bias, and rarely followed people beyond 12 weeks.

Adding TMS to medication is another approach under study. A 2025 meta-analysis of 29 trials found that rTMS plus medication improved GAD symptoms more than medication alone or sham stimulation plus medication. The authors urged caution because the trials varied widely.

Put plainly, TMS may turn the volume down on GAD symptoms for some people, but the trials are small and short, and they haven’t shown more people getting fully well.

What About PTSD, Panic Disorder, and OCD?

In a 2019 meta-analysis led by Massachusetts General Hospital researchers, PTSD was the most widely studied anxiety or trauma-related condition, and TMS showed a large overall effect for it. The 2026 RTI review rated the PTSD evidence as low strength, for the same reasons it gave for GAD.

Panic disorder and specific phobias have much less research. The 2019 review found too few studies with too few participants to draw conclusions for either one.

OCD is a different story, because TMS devices have been FDA-cleared for it since 2018. In the 2026 RTI review, active TMS produced more clinical responders than sham in 11 OCD trials, a finding it rated moderate strength. Our guide to how OCD is treated explains where TMS sits next to exposure therapy and medication.

What Is a Course of TMS Like?

TMS takes a real time commitment. NIMH describes a typical course as daily sessions five days a week for four to six weeks, with each session lasting anywhere from about 3 to 40 minutes. Accelerated protocols pack several sessions into a single day and can finish much faster. There’s no anesthesia, and the treatment happens in a clinic or office.

Side effects are usually mild and short-lived. NIMH lists:

• Discomfort where the coil sits on the head
• Tingling or twitching of scalp, jaw, or face muscles during a session
• Mild headaches or brief lightheadedness
• Dizziness

Seizures are possible, but NIMH notes the risk is low, and the 2026 RTI review found no difference in serious adverse events between active and sham TMS. NIMH also notes that long-term side effects haven’t been determined. If cost is part of your decision, our guides to TMS therapy cost and TMS insurance coverage walk through what to ask.

Who Might Be a Good Candidate for TMS?

The clearest candidates match the FDA clearances: adults with major depressive disorder and significant anxiety symptoms who haven’t improved enough on an antidepressant in their current episode. If that sounds like you, our guide to TMS for treatment-resistant depression covers the depression side in more depth.

If your anxiety stands on its own, TMS is still something you can discuss with a psychiatrist, but you’d be weighing an off-label use with weaker evidence. NIMH notes that brain stimulation should be prescribed and monitored by a provider with specific training and expertise.

A few questions are worth bringing to that conversation:

• Is my anxiety part of a depressive episode, or a separate anxiety disorder?
• Have I had a full trial of first-line treatment at an adequate dose and length?
• Which device and protocol would you use, and is it cleared for my condition?
• How will we measure whether it’s working?

What Should You Try Before TMS?

NIMH notes that brain stimulation therapies are usually used only after other treatments have been tried, and that a plan involving them usually also includes therapy, medication, or both. Before deciding standard care has failed, it’s worth checking whether you’ve had a full trial of it.

Many people never do. The World Mental Health Surveys covered 51,547 people in 21 countries. Among those with an anxiety disorder in the past year, 27.6% received any treatment and only 9.8% received treatment that met a basic adequacy standard, defined as at least a month of medication with four or more doctor visits, or eight or more visits for psychotherapy or other care.

The authors of the Lancet network meta-analysis also concluded that a first medication not working might not be a reason to give up on medication as a strategy. Antidepressants for anxiety take weeks to show their full effect, which our guide to how long anxiety medication takes to work explains. On the therapy side, our guide to cognitive behavioral therapy covers what a full course looks like.

How Siggy Fits In

Siggy doesn’t offer TMS. Siggy’s licensed prescribers diagnose and treat the full range of mental health conditions, including anxiety and depression, and first-line medications such as SSRIs are one option. The anonymous intake needs no name, email, or account, so you can describe what you’ve already tried, what helped, and what didn’t.

After intake, you get a downloadable summary you can keep or share with any clinician, including a TMS provider. That record matters, because the FDA clearances for anxiety with depression apply to people who haven’t improved enough on antidepressant medication. If medication may help you, a licensed prescriber reviews your full intake before anything is prescribed.

Siggy isn’t an emergency service. If you’re in crisis or thinking about suicide, call or text 988, or call 911 in a life-threatening situation. This article is for education only and isn’t a substitute for personal medical advice. It reflects sources available as of October 2026.

Start With an Honest Read of Where You Are

TMS is a legitimate option for anxiety that comes with depression, using devices FDA-cleared for that use, and a promising but still unproven one for anxiety disorders on their own. The biggest gains for most people still come from first-line care that’s given enough time and adjusted when it stalls. If you’re not sure whether your worry fits the picture of generalized anxiety, our guide to generalized anxiety disorder is a good place to compare. Start your anonymous intake and walk through your symptoms and treatment history in your own words. It’s free, a real doctor reviews every clinical decision, and the summary is yours to share with whoever helps you next.